Blog

Monthly Market Update - March 2025

Market Data – March 2025

Market Returns - 1 Month to 31 March 2025 (in AUD)

Market Commentary

The first quarter of 2025 was characterised by significant market volatility driven primarily by U.S. trade policy following President Trump's inauguration. Markets began the year positively but sentiment shifted as the administration imposed and threatened various tariffs—25% on Canada and Mexico (later postponed) and 10% on Chinese imports.

Global markets diverged considerably, with European equities outperforming, gaining approximately 10% in AUD terms, while U.S. markets retreated. The S&P 500 closed down 5% for the quarter, while the Nasdaq fell nearly 10% and the "Magnificent Seven" tech stocks plunged over 15%. The most dramatic single event was Chinese AI firm DeepSeek's emergence, which triggered NVIDIA's historic $600 billion single-day market value loss. Central banks showed diverging policies. The RBA cut rates in February by 25bps to 4.1%—its first reduction since 2020—while the Bank of Japan unexpectedly hiked rates to 0.5%. The Fed maintained rates amid mixed economic signals, lowering growth forecasts while raising inflation expectations. Bond markets demonstrated volatility but generally saw yields fall as recession concerns mounted. Commodities showed strength, with gold reaching record highs above $3,000 per ounce.

In Australia, the February reporting season revealed companies generally beating earnings expectations, though results weakened throughout the month, particularly in sectors like healthcare and retail. The ASX300 Banks Index shed 5.2% in February despite healthy credit growth and low bad debts, largely due to elevated valuations after strong 2024 performance. The quarter closed with emerging signs of stagflation, as personal spending in the U.S. rose just 0.1% in February alongside upticks in inflation data. This economic uncertainty fuelled defensive positioning, with investor sentiment deteriorating and economic policy uncertainty reaching multi-decade highs. Safe-haven assets benefited, with gold's record-breaking run reflecting the quarter's persistent volatility.

Australian Equities

The Prime Australian Equities Growth Portfolio declined 3.5% in March 2025, as global trade tensions and domestic economic concerns impacted investor sentiment across Australian markets. Despite challenging conditions, several key holdings demonstrated impressive resilience.

Resource exposures provided meaningful support, with Newmont Corporation emerging as the standout performer, surging 16.06% as gold prices rallied amid market uncertainty. Rio Tinto gained 6.36% as iron ore markets stabilised despite concerns about global demand. The energy sector contributed positively with Santos delivering a 1.83% return amid recovering oil prices.

Defensive allocations demonstrated their value, with Cleanaway Waste Management advancing 3.60% as investors favored businesses with reliable cash flows. The portfolio's cash position through the iShares Core Cash ETF provoved to be an important volatility buffer.

However, these positive contributions were outweighed by weakness in several key holdings such as James Hardie Industries, which plummeted 23.97% as concerns about housing market activity intensified. Financial services faced substantial headwinds with Macquarie Group falling 13.22%. Consumer discretionary stocks struggled as Premier Investments declined 12.20% with retail spending showing signs of moderation. Technology exposures continued their recent weakness, with Block declining 16.12% as the tech sector rotation persisted throughout the month.

The portfolio's balanced sector approach, combining quality cyclical exposures with defensive allocations, continues to navigate the current environment of elevated volatility. 

Defensive Income

March was a weak month of performance for global fixed income. Uncertainty surrounding the scope of impending tariffs continue to drive hesitation in global markets, as fears grow that we could see a slowing economy coupled with persistent elevated inflation (stagflation). The US 10y yield closed the month flat at 4.21%, falling from the intra-month high of 4.40% in the final two trading days. High yields widened considerably, up 67bps to 376bps on the CDX HY 5y spread.

The Australian bond market saw a slight steepening in the curve, particularly at the longer end. The domestic ACGB 10y yield increased 9bps to 4.38%, and our 2y yield fell 2bps to 3.68%. Domestic credit spreads were mixed, with quality outperforming. The AusBond Credit FRN OAS was flat at 62bps, whereas the AusBond Credit BBB- to BBB+ OAS widened 7bps to 124bps. Our 5y constant tenor Big Four Tier 2 FRN spread widened materially by 20bps to 164bps.

Prime delivered a return of +0.31% in March, which was a relatively strong result given market conditions. This performance contributed to an impressive 1y and 2y return of +6.73% and +6.47% p.a., outperforming the Bank Bill Index by +2.29% and +2.15%, respectively. Positively, this has been achieved with no negative months recorded since May 2023 (which was a modest negative 3bps). This excellent performance has been achieved while maintaining consistently low exposure to interest risk (~1.5y duration) and high credit quality (A- portfolio average credit rating).

The top performers for the Portfolio were Metrics Direct Income Fund (+0.78%) and MA Priority Income Fund (+0.69%), contributing weighted returns of +9bps and +8bps, respectively. PIMCO Global Bond Fund was the largest detractor (-3bps), driven by a -1.29% fall in market price as a function of offshore duration underperformance.

In the first month of trading MA1 remained largely par-bound and with healthy volumes. Comparitively, DN1 traded well initially however, volumes fell away even faster than anticipated. In April we have placed an order to reduce our exposure to DN1, with the expectation to also reduce MA1 over the coming months.

International Equities

The Prime International Growth Portfolio navigated a challenging market environment in March, declining 4.16% amid heightened uncertainty surrounding U.S. trade policies and mixed global economic signals. The portfolio's diversified approach demonstrated resilience as markets reacted to evolving geopolitical tensions.

European investments emerged as standout performers, with the iShares Europe ETF delivering a 3.1% gain. Value-oriented strategies similarly demonstrated their defensive merits, with the Pzena Global Focused Value Fund returning 2.3% and the Trinetra Emerging Markets Growth Trust adding stability with a 2.0% return.

These positive contributions were counterbalanced by pressure on growth-oriented holdings, particularly the Munro Concentrated Global Growth Fund which declined 3.7% as investor sentiment shifted away from high-valuation technology companies amid trade uncertainties. The substantial allocation to U.S. equities through the iShares S&P 500 ETF similarly detracted with a 3.2% decline.

Over the trailing twelve months, the portfolio's 8.86% return trailed the benchmark primarily due to differences in positioning. The underweight exposure to U.S. large-cap technology stocks, which drove significant benchmark returns during the S&P 500's strong rallies, particularly in the late 2024 post-election surge, accounted for much of the divergence. The portfolio's allocation to more diversified regional exposures and value-oriented strategies provided stability however generated subdued returns compared to the concentrated gains in U.S. markets. Emerging market and Japanese holdings were affected by trade policy uncertainties and currency fluctuations, further contributing to the relative performance divergence during a 12 month period characterised by narrow market leadership.

Contact

Mark Johnson
T: (03) 8825 4738
Marcus Ainger
T: (02) 9134 6292
Dylan Cresswell 
T: (03) 8825 4707
Brent Quinn
T: (03) 8825 4705
Livio Caiolfa 
T: (03) 8825 4748
Gina McIntosh
T: (07) 3557 2557
Jarrod Rodda 
T: (03) 8825 4729
Dylan Mayes ‍
T: (03) 8825 4742
 

The information in this article contains general advice and is provided by Primestock Securities Ltd AFSL 239180. That advice has been prepared without taking your personal objectives, financial situation or needs into account. Before acting on this general advice, you should consider the appropriateness of it having regard to your personal objectives, financial situation and needs. You should obtain and read the Product Disclosure Statement (PDS) before making any decision to acquire any financial product referred to in this article. Please refer to the FSG (www.primefinancial.com.au/fsg) for contact information and information about remuneration and associations with product issuers. This information should not be relied upon as a substitute for professional advice, and we encourage you to seek specific advice from your professional adviser before making a decision on the matters discussed in this article. Information in this article is current at the date of this article, and we have no obligation to update or revise it as a result of any change in events, circumstances or conditions upon which it is based.

Thank you for submitting your details, now you can download here.
Download Now
Oops! Something went wrong while submitting the form.
Thank you for submitting your details.
Oops! Something went wrong while submitting the form.

Take up this one-time exclusive offer and choose the service and expertise you need to make your SMSF work for you, speak to a specialist today to get started.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Terms & Conditions:
The promotion is not valid for cash or cash equivalent and is non-transferable. Cannot be combined with other offers, discount promotions or promotions. Promotions may be subject to availability. All monetary amounts specified in these terms and conditions are in Australian dollars (AUD). All pricing excludes GST. To redeem this promotion during the promotional period, you must complete the form submission included in the communication or landing page. Stock Doctor, Bell Direct and Prime reserves the right to modify or amend this promotion and cancel or suspend the promotion without prior notice. By completing the form or attempting to participate in this promotion, you agree to accept and be bound by these terms and conditions from StockDoctor, BellDirect and PrimeFinancial. The promotion from Bell Direct starts on Friday 27th October 2023 at 9:00 am AEDT and ends on Thursday 7th December 2023 at 5:00 pm AEDT. The promotion from Prime starts on Friday 27th October 2023 at 9:00 am AEDT and ends on Thursday 7th December 2023 at 5:00 pm AEDT. The promotion includes from StockDoctor: a 30-day complimentary membership to Stock Doctor. The promotion starts on Friday 27th Oct 2023 at 9:00 am AEDT and ends on Sunday 24th December 2023 at 5:00 pm AEDT and $200.00 AUD discount on new members joining Stock Doctor. The promotion starts on Friday 27th Oct 2023 at 9:00 am AEDT and ends on Sunday24th March 2024 at 5:00 pm AEDT.

Disclaimer:
This information has been prepared by Primestock Securities Limited ABN 67 089 676 068, AFSL 239180 ('Prime'). Prime accepts no obligation to correct or update the information or opinions in it. This information does not take into account your objectives, financial situation or needs. Before acting on this information, you should consider whether it is appropriate to your situation. It is recommended that you obtain financial, legal and taxation advice before making any financial investment decision. Prime is bound by the Australian Privacy Principles for the handling of personal information. Privacy Policy | Financial Services Guide

Lincoln Indicators Pty Limited (Lincoln) ABN 23 006 715 573, as Corporate Authorised Representative of Lincoln Financial Group Pty Ltd ABN 70 609 751966, AFSL 483167. This communication may contain general financial product advice or forward-looking statements regarding our intent, belief or current expectations with respect to the market conditions. Caution is advised in placing undue reliance on these forward-looking statements, as our advice has been prepared without taking account of your personal circumstances. Therefore, you should consider its appropriateness, in light of your objectives, financial situation and needs, before acting on it. Before acting on any advice, you should consider the appropriateness of the advice, and we recommend you obtain financial, legal and taxation advice before making a decision. Please refer to our Financial Services Guide (FSG) for more information at Lincoln Indicators Pty Ltd. If our advice relates to the acquisition or possible acquisition of a particular financial product, you should obtain a copy of and consider the Product Disclosure Statement (PDS) at Lincoln Indicators Pty Ltd before making any decision. 

The Bell Direct service is provided by Third Party Platform Pty Limited trading as "Bell Direct" (ABN 74 121 227 905) an Australian financial services licensee (AFSL 314341) a Participant of the ASX Limited Group and a Trading Participant of Cboe Australia. Bell Direct does not provide investment advice. You should consider your own financial situation, particular needs and investment objectives before acting on any of the information available at https://www.belldirect.com.au/.

Testimonials are provided by third parties for information purposes only and are not intended, and should not be taken to be financial product advice. Please refer to “Terms of Use”, “Important Information”, Terms and Conditions and The Privacy Policy Guide for StockDoctor, BellDirect and Prime for more information.

Contact details:
Email:
katea@primefinancial.com.au
Phone: 03 8825 4745

A unique and personal service approach to support all your business advisory and personal wealth management needs.

wealth strategies